Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,028B 10.75B 9.44B 8.76B 8.05B 15.22B 15.55B 104B 40.88B 505B 40.37B 39.48B 1,747B P/E 2027 *
24.5x
P/E 2028 * 19.6x
Enterprise Value 995B 10.41B 9.14B 8.48B 7.8B 14.73B 15.05B 101B 39.58B 489B 39.09B 38.23B 1,691B EV / Sales 2027 *
2.8x
EV / Sales 2028 * 2.47x
Free-Float
70.07%
Yield 2027 *
0.63%
Yield 2028 * 0.68%

Last Transcript: Dr. Reddy's Laboratories Limited

1 week-9.75%
Current month-9.03%
1 month-3.21%
3 months-0.11%
6 months+3.63%
Current year-2.90%
1 week 1,222
Extreme 1222
1,383
1 month 1,222
Extreme 1222
1,414.9
3 years 1,015.25
Extreme 1015.25
1,421.49
5 years 730.8
Extreme 730.8
1,421.49
10 years 374.59
Extreme 374.59
1,421.49
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-9.45%-1.61%+20.03% 10.87B
-0.56%-2.64%+49.04%+168.24% 1,060B
+0.31%-2.00%+64.29%+63.06% 619B
-0.03%-5.01%+28.86%+83.73% 438B
-1.75%-2.91%+28.78%+24.35% 333B
+0.24%-2.61%+29.46%+46.50% 282B
-1.75%-12.77%+20.67%+23.05% 267B
+0.67%-0.76%-26.10%-37.25% 218B
-0.81%-3.66%+22.07%+59.72% 196B
+1.21%+0.10%+19.85%+72.03% 161B
Average -0.40%-3.33%+23.53%+52.35% 397.1B
Weighted average by Cap. -0.06%-3.10%+36.16%+82.80%

Financials

2027 *2028 *
Net sales 356B 3.72B 3.27B 3.03B 2.79B 5.27B 5.38B 36.14B 14.15B 175B 13.98B 13.67B 605B 395B 4.13B 3.62B 3.36B 3.09B 5.84B 5.97B 40.07B 15.69B 194B 15.5B 15.16B 671B
Net income 42.23B 442M 388M 360M 331M 625M 639M 4.29B 1.68B 20.77B 1.66B 1.62B 71.76B 53.11B 555M 488M 453M 416M 786M 803M 5.39B 2.11B 26.12B 2.09B 2.04B 90.26B
Net Debt -32.67B -342M -300M -278M -256M -484M -494M -3.32B -1.3B -16.06B -1.28B -1.25B -55.51B -54.24B -567M -498M -462M -425M -803M -820M -5.51B -2.16B -26.67B -2.13B -2.08B -92.17B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
-
Date Price Change
26-07-13 ₹1,234.50 -0.79%
26-07-10 ₹1,244.30 -1.99%
26-07-09 ₹1,269.50 -5.89%
26-07-08 ₹1,349.00 -0.41%
26-07-07 ₹1,354.60 -0.97%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,234.60INR
Average target price
1,333.18INR
Spread / Average Target
+7.99%

Quarterly revenue - Rate of surprise